Ozempic maker Novo Nordisk to acquire obesity drug developer in $1B deal | The Hill
New ground for Novo: Denmark's largest company just keeps getting bigger
Find a job
Novo Nordisk adding in-house fill-finish capacity for Wegovy's European pen, Ozempic | Reuters
Novo Nordisk launches 'strong' guidance, warns of supply constraints | Reuters
Contact us | Novo Nordisk
Novo Nordiskt to invest more than 17 billion DKK in manufacturing facilities - Nordic Life Science – the leading Nordic life science news service
Novo Nordisk investing $117.4M in manufacturing site in Denmark | Fierce Pharma
Ozempic, Wegovy Maker Novo's Rise Forces Denmark to Keep Rates Lower: Danske - Bloomberg
Novo Nordisk builds R&D capacity in cardiovascular and liver diseases | Science | AAAS
Ozempic's Surging Popularity Has Novo Nordisk (NVO) Struggling to Meet Demand - Bloomberg
Who we Are | Novo Nordisk U.S.
Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs - Pharmaceutical Technology
Novo Nordisk invests DKK 5.4 bn Danish kroner in expansion of clinical manufacturing facilities in Bagsværd, Denmark - The Danish-UK Association
Novo Nordisk Headquarters – ArcDog
Novo Nordisk launches smart insulin pen in Denmark — MedWatch
Novo Nordisk, the maker of Wegovy and Ozempic is now Europe's most valuable company | CNN Business
The Novo Nordisk Foundation - Art Hub Copenhagen
Novo Nordisk Foundation
Novo Nordisk - JDRF
400 R&D jobs cut as Novo Nordisk says goodbye to inflammatory work
Novo Nordisk Corporate Center | Architect Magazine
Novo Nordisk to invest $2.3bn to expand manufacturing facilities
Novo Nordisk - Our Headquarters in Denmark has turned orange to mark #WorldPatientSafetyDay 🧡 Stay safe, everyone! | Facebook
Novo Nordisk expands research collaboration in novel delivery technologies for biologic medicines | Science|Business
Novo Nordisk | Official Profile
Novo Nordisk, Flagship's forward-thinking partnership aims to treat cardiometabolic, rare diseases | Fierce Biotech
Novo Nordisk Foundation - Wikipedia
